Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Fegueux

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Internal Medicine|December 19, 2018
Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remissionF Baron, M Labopin, A Ruggeri, et al.
Bone Marrow Transplantation|August 3, 2006
Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patientsP Quittet, P Ceballos, E Lopez, et al.
Bone Marrow Transplantation|January 10, 2024
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registryA Sadowska-Klasa, J M Zaucha, M Labopin, et al.
Bone Marrow Transplantation|July 1, 2014
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMTM A Kharfan-Dabaja, M Labopin, A Bazarbachi, et al.
Bone Marrow Transplantation|August 23, 2005
Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspectsJ-F Rossi, N Fegueux, Z Y Lu, et al.
Leukemia|July 6, 2007
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trialE Tavernier, J-M Boiron, F Huguet, et al.
Leukemia|May 17, 2003
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantationM Mohty, K Bilger, E Jourdan, et al.
Leukemia|August 15, 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL groupP Fenaux, S Chevret, A Guerci, et al.
Leukemia|May 13, 2005
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupC Callens, S Chevret, J-M Cayuela, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapyS de Botton, V Coiteux, S Chevret, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Internal Medicine|December 19, 2018
Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remissionF Baron, M Labopin, A Ruggeri, et al.
Bone Marrow Transplantation|August 3, 2006
Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patientsP Quittet, P Ceballos, E Lopez, et al.
Bone Marrow Transplantation|January 10, 2024
Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registryA Sadowska-Klasa, J M Zaucha, M Labopin, et al.
Bone Marrow Transplantation|July 1, 2014
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMTM A Kharfan-Dabaja, M Labopin, A Bazarbachi, et al.
Bone Marrow Transplantation|August 23, 2005
Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspectsJ-F Rossi, N Fegueux, Z Y Lu, et al.
Leukemia|July 6, 2007
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trialE Tavernier, J-M Boiron, F Huguet, et al.
Leukemia|May 17, 2003
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantationM Mohty, K Bilger, E Jourdan, et al.
Leukemia|August 15, 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL groupP Fenaux, S Chevret, A Guerci, et al.
Leukemia|May 13, 2005
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupC Callens, S Chevret, J-M Cayuela, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapyS de Botton, V Coiteux, S Chevret, et al.
Pageof 3